The Society for Pharmaceutical Dissolution Science (SPDS) will be holding its 5th annual international convention ,Disso India- Mumbai 2017 on June 8 and 9, 2017 at Hotel The Leela, Mumbai. The event aims to promote introduction of new technology, innovation and will have deliberations on various issues related to dissolution.
Eminent professionals from the pharmaceutical industry will take part in the event. This event is being organised under the Chairmanship of Dr. K. Bangarurajan, Deputy Drugs Controller, DDC(India),Central Drugs Standard Control Organization, West Zone and the Organizing Secretary, Dr. L. Ramaswamy, Managing Director, SOTAX India Pvt Ltd.
The scientific sessions are programmed and executed under the chairmanship of Prof. Padma V. Devarajan , Professor in Pharmacy, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology and Dr. Vinod P. Shah, Ex. US FDA, Pharmaceutical Consultant, USA.
The event will comprise plenary lecture, panel discussions, exhibits and a poster session.
Disso India 2017 will have exceptional global speakers such as Dr. Roger Willam, EX- CEO USP, Ex US FDA, USA talking on Regulation Science: the paradigm of Dissolution ; Dr. Vinod P. Shah, Ex. US FDA, Pharmaceutical Consultant, USA, speaking on Scientific basis for Topical drug Classification System (TCS); Prof. Dr. Jennifer Dressman, Institute of Pharmaceutical Technology, Biocenter, Johann Wolfgang Goethe University, Germany talking on GI physiology and need for selective dissolution media and also on Advantages and impact of Biorelevant Dissolution Media; Vijay Kshirsagar, Director and CEO, TRAC Pharma Consulting, Mumbai talking on QbD in Dissolution - Case studies; Dr. Saranjit Singh, Professor & Head, Pharmaceutical Analysis, NIPER, talking on Role of Dissolution in evaluating stability and lifespan of the formulation; Prof. Dr. Umesh Banakar, Professor and President, Banakar Consulting Services, USA talking on Patentability of a product based on Disso data; Prof. Dr. Raghunandan H.V, Deputy Director- Academics, JSS University, Mysore talking on Quality Metrics for better compliance; Prof. Dr. Umesh Banakar, Professor and President, Banakar Consulting Services, USA, talking on Data Integrity issues in Dissolution based factors affecting bioavailability; Michel Magnier, Product Manager and Application specialist, SOTAX AG, Switzerland , talking on Automation in Dissolution testing, Dr.Chetan Pujara, Vice President, Small Molecule Product Development, Allergan, USA , talking on Complexity of invitro drug release measurements for ophthalmic drug products; Dr. Abhijit V Gothoskar, Technical Advisor, Anshul Life Sciences, talking on Drug dissolution: Excipient vs Excipient; Manu Grover, Waters India Pvt Ltd talking on Risk Assessment of Analytical Methods w.r.t dissolution testing and Dr. (Mrs) Parizad A Elchidana, GMP Scientific Inc talking on Incorporating physiologically based pharmacokinetic (PBPK) modeling to assist with dissolution method development, IVIVC and successful biowaivers.
Disso India Mumbai -2017 is specifically designed for all the professionals from R&D, QA and QC as well as the Academia. Around 200 delegates are expected to participated in this mega symposium focussing on dissolution.
For more details on Disso India Mumbai -2017 and other upcoming programmes of SPDS, log on to www.spds.in